Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I
Recruiting
N/A
Interventional Study
Glycogen Storage Disease Type I
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The present project will specifically assess metabolic effects of dietary interventions with controlled intake of fructose and fructose/galactose in GSDI, with the aim to provide evidence whether relaxed dietary restrictions of fructose and galactose may be justified in treatment recommendations at least for adults, which would considerably enlarge food choice in everyday life of the patients with…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Genetically and/or enzymatically confirmed diagnosis of GSDI (GSDIa or GSDIb)
* Male or female ≥ 18y
* Restriction of fructose intake in usual dietary treatment
* Written informed consent
Exclusion Criteria:
* Non-compliance with routine dietary treatment
* Pregnancy or lact…
Contacts